Article Details
Retrieved on: 2021-04-22 21:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
PURPOSE: Sabatolimab (MBG453) and spartalizumab are monoclonal antibodies that bind T-cell immunoglobulin domain and mucin domain-3 ...
Article found on: www.docwirenews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here